Financial Statements — CBRS
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Cash & Equivalents | 6.74 | 1.72 |
| Accounts Receivable | 0.12 | 0.06 |
| Inventory | 0.03 | 0.09 |
| Total Current Assets | 9.12 | 3.58 |
| Property, Plant & Equipment | 0.99 | 0.57 |
| Total Non-current Assets* | 2.51 | 1.37 |
| Total Assets | 11.63 | 4.95 |
| Accounts Payable | 0.09 | 0.05 |
| Short-term Debt | -- | 0.62 |
| Total Current Liabilities | 1.57 | 1.43 |
| Long-term Debt | 0.18 | 0.36 |
| Total Non-current Liabilities* | 0.91 | 0.77 |
| Total Liabilities | 2.47 | 2.20 |
| Retained Earnings | (1.37) | (0.92) |
| Total Stockholder Equity | 9.15 | (0.19) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 |
|---|
| Total Revenue | 180.11 | 193.41 |
| Cost of Revenue | 154.55 | 107.23 |
| Gross Profit | 25.56 | 86.18 |
| Research & Development | 320.15 | 75.50 |
| Selling, General & Admin | 95.67 | 11.02 |
| Total Operating Expenses | 502.79 | 101.21 |
| Operating Income | (477.23) | (15.04) |
| Pretax Income | (450.25) | (12.51) |
| Tax Provision | 0.27 | 1.50 |
| Net Income | (450.53) | (14.01) |
| Basic EPS | (2.98) | (0.22) |
| Diluted EPS | (2.98) | (0.22) |
Cash Flow Statement
(in billions USD)| Metric | Q2
2026 | Q1
2026 |
|---|
| Operating Cash Flow | (0.06) | 0.01 |
| Capital Expenditures | 0.42 | 0.13 |
| Free Cash Flow* | (0.48) | (0.12) |
| Investing Cash Flow | (1.07) | (0.24) |
| Financing Cash Flow | 5.82 | 2.04 |
* Derived from reported values
